ENZYMES dcm.pdf

M
Enzymology=ENZYMES
Kmtc
=
Charles Ng’ang’a
KMTC Msambweni
Clinical medicine
Abbrev’
• NAD(H) = nicotinamide adenine dinucleotide;
• THF = tetrahydrofolate
• CoA = coenzyme A.
• TCA = tricarboxylic acid
• PP = pentose phosphate
ENZYMES dcm.pdf
Definition
• it is derived from the Greek words en (meaning ‘within’) and zume
(meaning ‘yeast’).
• Enzymes are biological catalysts (also known as biocatalysts) that speed up
biochemical reactions in living organisms
• -=Enzymes are protein catalysts that increase the velocity of a chemical
reaction and are not consumed during the reaction.
• can be extracted from cells and then used to catalyse a wide range of
commercially important processes
NAMING
• Most commonly used enzyme names have the suffix “-ase” attached
to the substrate of the reaction (for example, glucosidase and urease)
or to a description of the action performed (for example, lactate
dehydrogenase and adenylyl cyclase).
• [Note: Some enzymes retain their original trivial names, which give
no hint of the associated enzymic reaction, for example, trypsin and
pepsin
Enzyme names and classification
• Enzymes typically have common names (often called ‘trivial names’) which
refer to the reaction that they catalyse, with the suffix -ase (e.g. oxidase,
dehydrogenase, carboxylase), although individual proteolytic enzymes
generally have the suffix -in (e.g. trypsin, chymotrypsin, papain).
• Often the trivial name also indicates the substrate on which the enzyme acts
(e.g. glucose oxidase, alcohol dehydrogenase, pyruvate decarboxylase).
• However, some trivial names (e.g. invertase, diastase, catalase) provide little
information about the substrate, the product or the reaction involved
History
• History of Enzymes 1878: Name was used when he was describing the ability
of yeast to produce alcohol from sugars
• 1897: Eduard Buchner began to study the ability of yeast extracts that lacked
any living yeast cells to ferment sugar.
• He found that the sugar was fermented even when there were no living yeast
cells in the mixture.
He named the enzyme that brought about the fermentation of sucrose
"zymase".
History
• In 1907 he received the Nobel Prize in Chemistry “for his biochemical research
and his discovery of cell-free fermentation".
• 1920s that enzymes were crystallized, revealing that catalytic activity is
associated with protein molecules.
• For the next 60 years or so it was believed that all enzymes were proteins
• 1980s it was found that some ribonucleic acid (RNA) molecules(ribozymes) are
also able to exert catalytic effects and play an important role in gene
expression
Significance
They have important roles
i. The production of sweetening agents –used within the food-processing industry
ii. Modification of antibiotics
iii. Enzymes that are used as diagnostic reagents and in clinical therapeutics . Glucose--
iv. They are used in washing powders and various cleaning products-proteases for use in
washing powders
v. They play a key role in analytical devices and -assays Elisa-that have clinical, forensic
and environmental applications.-Technical advantages-Microorganisms are also very
amenable to genetic modification to produce novel or altered enzymes, using relatively
simple methods
vi. Enzymes are essential components of animals, plants and microorganisms, due to the
fact that they catalyse and co-ordinate the complex reactions of cellular metabolism
Glucose--- glucometer
Enzymes may be intracellular or extracellular
• Although many enzymes are retained within the cell, and may be located in
specific subcellular compartments, others are released into the surrounding
environment.
• The majority of enzymes in industrial use are extracellular proteins from either
fungal sources (e.g. Aspergillus species) or bacterial sources (e.g. Bacillus
species). Examples of these include α-amylase, cellulase, dextranase, proteases
and amyloglucosidase.
• Many other enzymes for non-industrial use are intracellular and are produced in
much smaller amounts by the cell. Examples of these include asparaginase,
catalase, cholesterol oxidase, glucose oxidase and glucose-6-phosphate
dehydrogenase
Catalytic efficiency
• Enzyme-catalyzed reactions are highly efficient, proceeding from 103–108
times faster than uncatalyzed reactions.
• The number of molecules of substrate converted to product per enzyme
molecule per second is called the turnover number, or k cat, and typically
is 102–104s-1.
Specificity
• Enzymes are highly specific, interacting with one or a few substrates
and catalyzing only one type of chemical reaction.
• The set of enzymes made in a cell determines which reactions occur
in that cell.
Holoenzymes, apoenzymes, cofactors, and coenzymes
• Some enzymes require molecules other than proteins for enzymic activity.
• The term holoenzyme refers to the active enzyme with its nonprotein component,
• whereas the enzyme without its nonprotein moiety is termed an apoenzyme and
is inactive.
• If the nonprotein moiety is a metal ion, such as Zn2+ or Fe2+, it is called a cofactor
• If it is a small organic molecule, it is termed a coenzyme.
• Coenzymes that only transiently associate with the enzyme are called
cosubstrates.
• If the coenzyme is permanently associated with the enzyme and
returned to its original form, it is called a prosthetic group (FAD .
Coenzymes commonly are derived from vitamins.
• For example, NAD+ contains niacin, and FAD contains riboflavin
Regulation
• Enzyme activity can be regulated, that is, increased or
decreased, so that the rate of product formation responds
to cellular need.
Location within the cell
• Many enzymes are localized in specific organelles within the cell.
• Such compartmentalization serves to isolate the reaction substrate or
product from other competing reactions.
• This provides a favorable environment for the reaction and organizes the
thousands of enzymes present in the cell into purposeful pathways.
HOW ENZYMES WORK
• The mechanism of enzyme action can be viewed from two different perspectives.
• The first treats catalysis in terms of energy changes that occur during the reaction.
• That is, enzymes provide an alternate, energetically favorable reaction pathway
different from the uncatalyzed reaction.
• The second perspective describes how the active site chemically
• facilitates catalysis.
Action of Enzymes
• As catalysts, enzymes are only required in very low concentrations, and
they speed up reactions without themselves being consumed during the
reaction.
• We usually describe enzymes as being capable of catalysing the
conversion of substrate molecules into product molecules as follows:
• Enzyme
Substrate ↔ Product
Active sites
• Enzyme molecules contain a special pocket or cleft called the active site.
• The active site, formed by folding of the protein, contains amino acid side
chains that participate in substrate binding and catalysis.
• The substrate binds the enzyme, forming an enzyme–substrate (ES) complex.
Binding is thought to cause a conformational change in the enzyme (induced fit
model) that allows catalysis.
• ES is converted to an enzyme–product (EP) complex that subsequently
dissociates to enzyme and product
ENZYMES dcm.pdf
Effect of an enzyme on reducing the activation energy required to start a
reaction where (a) is uncatalysed and (b) is enzyme-catalysed reaction
Formation of product in an enzyme-catalysed reaction, plotted against time.
Enzymes are affected by pH and temperature
• Various environmental factors are able to affect the rate of enzyme-
catalysed reactions through reversible or irreversible changes in the
protein structure.
• The effects of pH and temperature are generally well understood.
• Most enzymes have a characteristic optimum pH at which the velocity of
the catalysed reaction is maximal, and above and below which the
velocity declines
ENZYMES dcm.pdf
• Thermal denaturation is time dependent, and for an enzyme the term
‘optimum temperature’ has little real meaning unless the duration of
exposure to that temperature is recorded.
• The thermal stability of an enzyme can be determined by first
exposing the protein to a range of temperatures for a fixed period of
time, and subsequently measuring its activity at one favourable
temperature (e.g. 25°C).
ENZYMES dcm.pdf
inhibitors
• Enzymes are sensitive to inhibitors
• Substances that reduce the activity of an enzyme-catalysed reaction are known as
inhibitors.
• They act by either directly or indirectly influencing the catalytic properties of the active
site.
• Inhibitors can be foreign to the cell or natural components of it.
• Those in the latter category can represent an important element of the regulation of cell
metabolism.
• Many toxins and also many pharmacologically active agents (both illegal drugs and
prescription and over-the counter medicines) act by inhibiting specific enzyme-catalysed
assignment
•Students to do
• Competitive inhibitors
• Non-competitive
Allosteric regulators and the control of enzyme activity
• Allosteric enzymes are key regulatory enzymes that control the activities of
metabolic pathways by responding to inhibitors and activators
• allosteric enzymes there is an area where activity is lower than that of an
equivalent ‘normal’ enzyme, and also an area where activity is higher than
that of an equivalent ‘normal’ enzyme, with a rapid transition between these
two phases.
• This is rather like a switch that can quickly be changed from ‘off’ (low activity)
to ‘on’ (full activity
• Most allosteric enzymes are polymeric—that is, they are composed of at least two
(and often many more) individual polypeptide chains.
• They also have multiple active sites where the substrate can bind.
• Allosteric enzymes have an initially low affinity for the substrate, but when a
single substrate molecule binds, this may break some bonds within the enzyme and
thereby change the shape of the protein such that the remaining active sites are
able to bind with a higher affinity.
• Therefore allosteric enzymes are often described as moving from a tensed state or
T-state (low affinity) in which no substrate is bound, to a relaxed state or R-state
(high affinity) as substrate binds
Allosteric regulators and the control of enzyme activity
FACTORS AFFECTING REACTION VELOCITY
A. Substrate concentration
• The rate or velocity of a reaction (v) is the number of substrate molecules converted
to product per unit time.
• Velocity is usually expressed as μmol of product formed per minute.
• The rate of an enzyme-catalyzed reaction increases with substrate concentration
until a maximal velocity (Vmax) is reached.
• The leveling off of the reaction rate at high substrate concentrations reflects the
saturation with substrate of all available binding sites on the enzyme molecules
• present.
• B. Temperature
• Increase of velocity with temperature:
• The reaction velocity increases with temperature until a peak velocity is reached .
• This increase is the result of the increased number of molecules having sufficient energy to
pass over the energy barrier and form the products of the reaction.
• Decrease of velocity with higher temperature:
• Further elevation of the temperature causes a decrease in reaction velocity as a result of
temperature induced denaturation of the enzyme
• Nb; The optimum temperature for most human enzymes is between 35°C
and 40°C.
• Human enzymes start to denature at temperatures above 40°C, but thermophilic
bacteria found in the hot springs have optimum temperatures of 70°C.
FACTORS AFFECTING REACTION VELOCITY
• C. pH
• The concentration of protons (H+) affects reaction velocity in several ways
• catalytic process usually requires that the enzyme and substrate have specific chemical
groups in either an ionized or un-ionized state in order to interact .e.g. catalytic activity
may require that an amino group of the enzyme be in the protonated form (–NH3+).
• Effect of pH on enzyme denaturation:
• Extremes of pH can also lead to denaturation of the enzyme, because the structure of the
catalytically active protein molecule depends on the ionic character of the amino acid side
chains
FACTORS AFFECTING REACTION VELOCITY
PH cont’d
• Variable pH optimum: The pH at which maximal enzyme activity is achieved
is different for different enzymes and often reflects the [H+] at which the
enzyme functions in the body.
• For example, pepsin, a digestive enzyme in the stomach, is maximally active
at pH 2, whereas other enzymes, designed to work at neutral pH, are
denatured by such an acidic environment
Name of the enzyme Optimum pH
Trypsin 7.6
Pepsin 2-2.5
Acid phosphatase 5
Alkline phosphatase 9-10
1. Metabolic pathways are controlled by regulating enzyme activity. If enzyme activity is
not regulated, it can harm cellular activities and may lead to the development of
diseases
Activity/substrate profiles of allosteric (⚬) and non-allosteric (•) enzymes with the
same affinity and maximal velocity
Enzyme
Substrate ↔ Product
Action of Enzymes
First EC digit
Oxidoreductases
PROPERTIES OF ENZYMES
e-mail:
charlesnganga069a@gmail.com
Catalytic Property, Specificity, Reversibility,
and Sensitivity to Heat and pH
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
ENZYMES dcm.pdf
For detailed description of this topic, please click on:
https://www.easybiologyclass.com/properties-of-enzymes-
biochemistry-lecture-notes/
Nature of Enzymes
• Enzymes are specific catalysts
• enzymes also possess remarkable specificity in that they generally catalyse
the conversion of only one type (or at most a range of similar types) of
substrate molecule into product molecules. E.g. glucose oxidase shows
almost total specificity for its substrate, β-D-glucose
Nature of Enzymes
• Two categories dependant on: the presence and absence of a nonprotein
component
i. Simple enzyme: made up of only protein molecules not bound to
any nonproteins, e.g. Pancreatic Ribonuclease.
ii. Holo enzyme(apoenzyme) -made up of protein groups and non-
protein component. non-protein component here includes- (Fe
2+, Mn 2+, or Zn 2+ ions).
COENZYMES
a) Coenzymes are derivatives of vitamins without which the enzyme cannot
exhibit any reaction. One molecule of coenzyme is able to convert a large
number of substrate molecules with the help of enzyme.
i. Coenzyme accepts a particular group removed from the substrate or
donates a particular group to the substrate
ii. Coenzymes are called co substrate because the changes that take place
in substrates are complimentary to the changes in coenzymes.
iii. The coenzyme may participate in forming an intermediate enzyme-
substrate complex Example: NAD, FAD, Coenzyme A
Metal ions in enzymes
Many enzymes require metal ions like ca2+, K+, Mg2+, Fe2+, Cu2+, Zn2+,
Mn2+ and Co2+ for their activity.
Metal-activated enzymes-form only loose and easily dissociable complexes
with the metal and can easily release the metal without Denaturation.
Metalloenzymes hold the metal tightly on the molecule and do not release
it even during extensive purification.
Metal ions in enzymes
Metal ions promote enzyme action by
•Maintaining or producing the active structural conformation of the enzyme
(e.g. glutamine synthase)
•Promoting the formation of the enzyme-substrate complex (Example: Enolase
and carboxypeptidase A.)
•Acting as electron donors or acceptors (E.g. : Fe-S proteins and cytochromes)
•Causing distortions in the substrate or the enzyme E.g. phosphotransferases).
The six major classes of
enzymes with some example
are
The six major classes of enzymes with some example are
1. Oxidoreductases
• They catalyze oxidation and reduction reactions
2. Tranferases
• They catalyze transfer of groups
3. Hydrolases
• They catalyze hydrolysis of peptide, ester, glycosyl etc. bonds
• 4. Lyases
• They catalyze removal of groups from substrates by mechanisms other than hydrolysis forming
double bonds
The six major classes of enzymes with some example are
• 5. Isomerases
• They catalyze interconversion of optical, functional and geometrical isomers.
• 6. Ligases
• They catalyze linking together of two compounds. The linking is coupled to
the breaking of phosphate from ATP
clinically important enzymes
• Some of the clinically important enzymes which are routinely measured in clinical
chemistry laboratory are:
1. Alkaline phosphatase
• This enzyme catalyzes the hydrolysis of organic esters at alkaline pH 9.0, hence
the name alkaline phosphatase. The normal level is 20-90 units/L. The level of
the enzyme is elevated in rickets, obstructive jaundice, hyper para thyroidism,
metastatic cancer, bone cancer and osteomalacia. In obstructive jaundice
2. Acid phosphatase
• This enzyme catalyzes the hydrolysis of organic esters at acidic pH (5.0) hence
the name acid phosphatase. The normal level of the enzyme is 2.5-12.0 units/L.
It is increased in prostrate cancer. Small increase are seen in bone disease and
breast cancer
3. Transminases
Aspartate aminoa transferase (AST) and alanine amino transferase
(ALT) are two transaminases most frequently measured. Normal levels
are 3-20 U/L for AST and 4-20 U/L for ALT (Units-U).
clinically important enzymes
4. γ-glutamyl trans peptidase (GGT)
• It is involved in the degradation of glutathione. Its level is increased in alcoholic cirrhosis.
The normal plasma level of GGT is less than 30 units/L. Since this enzyme is secreted into
bile by liver, like alkaline phosphatase γ-glutamyl trans peptidase level increases in
cholestatic or obstructive jaundice. It is also elevated in brain lesions.
5. Creatine phosphokinase (CK)
• The normal level of this enzyme in plasma is 12-60 U/l. Since skeletal muscle is rich in CK
serum CK level raises in disease effecting skeletal muscle. Its level is elevated in muscular
dystrophy, polymyositis, severe muscle exercise, muscle injury, hypothyroidism, epileptic
seizures and in tetanus.
• CK level is also elevated in diseases affecting cardiac muscle because of its high content in
it. CK level is elevated in myocardial infarction
clinically important enzymes
6. Lactate dehydrogenase (LDH)
• The LDH normal level is 70-90 units/L. LDH levels are elevated in myocardial
infraction. The serum LDH level raises within 24 hours after infraction, reaches
peak level around 2-3 days and returns to normal in a week. Serum LDH level is
also elevated in pernicious anemia, megaloblastic anemia, acute hepatitis, blood
cancer and in progressive muscular dystrophy.
7. Isocitrate dehydrogenase
• The normal level of this enzyme in plasma is 1-5 Units/L. Its level is elevated in
inflammatory diseases of liver like infective heptatitis, toxic hepatitis. In
obstructive jaundice, its level
clinically important enzymes
8. Amylase
• The normal range of this enzyme in plasma is 800-1800 Units/L. This enzyme is
secreted by pancreas and salivary glands. So, its level is elevated mainly in acute
pancreatitis and parotitis.
• Its level raised in other conditions like intestinal obstruction and in mumps.
9. Lipase
• It is an enzyme produced by pancreas. It is secreted into duodenum through
pancreatic duct. The normal level of this enzyme is up to 150 Units/L. It is mainly
elevated in acute pancreatitis and pancreas cancer.
• It is also elevated in patients with abdominal lesions, perforated peptic ulcer,
intestinal obstruction and in acute peritonitis.
charles ng'ang'a d/cm march 2020
1 de 69

Recomendados

Enzymes b.pharm por
Enzymes b.pharmEnzymes b.pharm
Enzymes b.pharmKamlesh Yadav
15.7K visualizações75 slides
Enzymes.pptx por
Enzymes.pptxEnzymes.pptx
Enzymes.pptxAlyssaMaeAzarcon
19 visualizações24 slides
Enzymes (1) por
Enzymes (1)Enzymes (1)
Enzymes (1)Cleophas Rwema
432 visualizações78 slides
Plant physiology ppt 1.pptx por
Plant physiology ppt 1.pptxPlant physiology ppt 1.pptx
Plant physiology ppt 1.pptxSseruwoJohnson
12 visualizações33 slides
Enzymes.pptx por
 Enzymes.pptx Enzymes.pptx
Enzymes.pptxberciyalgolda1
239 visualizações43 slides
JAndrew/ENZYMES.pptx por
JAndrew/ENZYMES.pptxJAndrew/ENZYMES.pptx
JAndrew/ENZYMES.pptxshakinadeiv1
82 visualizações40 slides

Mais conteúdo relacionado

Similar a ENZYMES dcm.pdf

Overview of enzyme por
Overview of enzymeOverview of enzyme
Overview of enzymeSir Parashurambhau College, Pune
537 visualizações38 slides
Enzymes Biochemistry por
Enzymes BiochemistryEnzymes Biochemistry
Enzymes BiochemistryKalaivanisathishr
118.4K visualizações63 slides
UNIT-3 BACTERIAL ETABOLISM.pptx por
UNIT-3 BACTERIAL ETABOLISM.pptxUNIT-3 BACTERIAL ETABOLISM.pptx
UNIT-3 BACTERIAL ETABOLISM.pptxAyushiSharma843565
7 visualizações25 slides
Catalysis lecture 4 por
Catalysis lecture 4Catalysis lecture 4
Catalysis lecture 4Dr. Rabiul Hussain
103 visualizações15 slides
CHAPTER 6.pptx por
CHAPTER 6.pptxCHAPTER 6.pptx
CHAPTER 6.pptxSayali Powar
133 visualizações46 slides
Enzymes por
EnzymesEnzymes
EnzymesNabeen Patra
3.3K visualizações127 slides

Similar a ENZYMES dcm.pdf(20)

Enzymes Biochemistry por Kalaivanisathishr
Enzymes BiochemistryEnzymes Biochemistry
Enzymes Biochemistry
Kalaivanisathishr118.4K visualizações
UNIT-3 BACTERIAL ETABOLISM.pptx por AyushiSharma843565
UNIT-3 BACTERIAL ETABOLISM.pptxUNIT-3 BACTERIAL ETABOLISM.pptx
UNIT-3 BACTERIAL ETABOLISM.pptx
AyushiSharma8435657 visualizações
Catalysis lecture 4 por Dr. Rabiul Hussain
Catalysis lecture 4Catalysis lecture 4
Catalysis lecture 4
Dr. Rabiul Hussain103 visualizações
CHAPTER 6.pptx por Sayali Powar
CHAPTER 6.pptxCHAPTER 6.pptx
CHAPTER 6.pptx
Sayali Powar133 visualizações
Enzymes por Nabeen Patra
EnzymesEnzymes
Enzymes
Nabeen Patra3.3K visualizações
Enzymes Advance por Muhammadasif909
Enzymes AdvanceEnzymes Advance
Enzymes Advance
Muhammadasif9098.7K visualizações
ENZYMES.pptx por Perfect40
ENZYMES.pptxENZYMES.pptx
ENZYMES.pptx
Perfect4029 visualizações
Enzymes and enzymes inhibition, GPCR por AbhishekJoshi312
Enzymes and enzymes inhibition, GPCREnzymes and enzymes inhibition, GPCR
Enzymes and enzymes inhibition, GPCR
AbhishekJoshi312147 visualizações
Enzymes.pptx por Vishnu988156
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
Vishnu98815620 visualizações
Enzymes por Zainab&Sons
EnzymesEnzymes
Enzymes
Zainab&Sons521 visualizações
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme por Arun Kumar
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY EnzymeD. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
Arun Kumar679 visualizações
Unit 4: Plasma Enzyme tests in diagnosis por DrElhamSharif
Unit 4: Plasma Enzyme tests in diagnosis Unit 4: Plasma Enzyme tests in diagnosis
Unit 4: Plasma Enzyme tests in diagnosis
DrElhamSharif4.2K visualizações
enzymes, DE.ppt por AmirBala4
enzymes, DE.pptenzymes, DE.ppt
enzymes, DE.ppt
AmirBala412 visualizações
Enzymes por sjykmuch
EnzymesEnzymes
Enzymes
sjykmuch4.3K visualizações
Regulatory and allosteric enzymes and allostrerism por Ayetenew Abita Desa
Regulatory and allosteric enzymes and allostrerismRegulatory and allosteric enzymes and allostrerism
Regulatory and allosteric enzymes and allostrerism
Ayetenew Abita Desa12.5K visualizações
Bmm480 Enzymology lecture-1 por hüsamettin kaplan
Bmm480 Enzymology lecture-1Bmm480 Enzymology lecture-1
Bmm480 Enzymology lecture-1
hüsamettin kaplan2.5K visualizações

Mais de MishiSoza

GROUP 7 SURGERY ASSIGNMENT.-1.pptx por
GROUP 7 SURGERY ASSIGNMENT.-1.pptxGROUP 7 SURGERY ASSIGNMENT.-1.pptx
GROUP 7 SURGERY ASSIGNMENT.-1.pptxMishiSoza
3 visualizações22 slides
LFTs.pdf por
LFTs.pdfLFTs.pdf
LFTs.pdfMishiSoza
13 visualizações64 slides
Valvular heart disease.ppt por
Valvular heart disease.pptValvular heart disease.ppt
Valvular heart disease.pptMishiSoza
6 visualizações54 slides
2 b. ABDOMINAL AORTA1.ppt por
2 b. ABDOMINAL AORTA1.ppt2 b. ABDOMINAL AORTA1.ppt
2 b. ABDOMINAL AORTA1.pptMishiSoza
39 visualizações38 slides
5.Fractures (Broken Bones).ppt por
5.Fractures (Broken Bones).ppt5.Fractures (Broken Bones).ppt
5.Fractures (Broken Bones).pptMishiSoza
7 visualizações20 slides
research proposal.pptx por
research proposal.pptxresearch proposal.pptx
research proposal.pptxMishiSoza
4 visualizações8 slides

Mais de MishiSoza(20)

GROUP 7 SURGERY ASSIGNMENT.-1.pptx por MishiSoza
GROUP 7 SURGERY ASSIGNMENT.-1.pptxGROUP 7 SURGERY ASSIGNMENT.-1.pptx
GROUP 7 SURGERY ASSIGNMENT.-1.pptx
MishiSoza3 visualizações
LFTs.pdf por MishiSoza
LFTs.pdfLFTs.pdf
LFTs.pdf
MishiSoza13 visualizações
Valvular heart disease.ppt por MishiSoza
Valvular heart disease.pptValvular heart disease.ppt
Valvular heart disease.ppt
MishiSoza6 visualizações
2 b. ABDOMINAL AORTA1.ppt por MishiSoza
2 b. ABDOMINAL AORTA1.ppt2 b. ABDOMINAL AORTA1.ppt
2 b. ABDOMINAL AORTA1.ppt
MishiSoza39 visualizações
5.Fractures (Broken Bones).ppt por MishiSoza
5.Fractures (Broken Bones).ppt5.Fractures (Broken Bones).ppt
5.Fractures (Broken Bones).ppt
MishiSoza7 visualizações
research proposal.pptx por MishiSoza
research proposal.pptxresearch proposal.pptx
research proposal.pptx
MishiSoza4 visualizações
SEROTONIN.pptx por MishiSoza
SEROTONIN.pptxSEROTONIN.pptx
SEROTONIN.pptx
MishiSoza4 visualizações
FURUNCLE.ppt por MishiSoza
FURUNCLE.pptFURUNCLE.ppt
FURUNCLE.ppt
MishiSoza220 visualizações
Behavioral Science.ppt por MishiSoza
Behavioral Science.pptBehavioral Science.ppt
Behavioral Science.ppt
MishiSoza6 visualizações
INTRODUCTION TO IMCNI. updated.pptx por MishiSoza
INTRODUCTION TO IMCNI. updated.pptxINTRODUCTION TO IMCNI. updated.pptx
INTRODUCTION TO IMCNI. updated.pptx
MishiSoza46 visualizações
2. Assess & Classify age 2 months upto 5 yrs.pptx por MishiSoza
2. Assess & Classify age 2 months upto 5 yrs.pptx2. Assess & Classify age 2 months upto 5 yrs.pptx
2. Assess & Classify age 2 months upto 5 yrs.pptx
MishiSoza45 visualizações
CHEST INJURY GROUP FOUR.pptx por MishiSoza
CHEST INJURY GROUP FOUR.pptxCHEST INJURY GROUP FOUR.pptx
CHEST INJURY GROUP FOUR.pptx
MishiSoza5 visualizações
CHEST CONDITION-DCM 2021.pptx por MishiSoza
CHEST CONDITION-DCM 2021.pptxCHEST CONDITION-DCM 2021.pptx
CHEST CONDITION-DCM 2021.pptx
MishiSoza7 visualizações
HYPERTENSION.pptx por MishiSoza
HYPERTENSION.pptxHYPERTENSION.pptx
HYPERTENSION.pptx
MishiSoza5 visualizações
Behavioral Science (2).ppt por MishiSoza
Behavioral Science (2).pptBehavioral Science (2).ppt
Behavioral Science (2).ppt
MishiSoza4 visualizações
PEDIATRIC HISTORY.ppt por MishiSoza
PEDIATRIC HISTORY.pptPEDIATRIC HISTORY.ppt
PEDIATRIC HISTORY.ppt
MishiSoza41 visualizações
Surface anatomy areas.pptx por MishiSoza
Surface anatomy areas.pptxSurface anatomy areas.pptx
Surface anatomy areas.pptx
MishiSoza56 visualizações
CVS lssn 2.pptx por MishiSoza
CVS lssn 2.pptxCVS lssn 2.pptx
CVS lssn 2.pptx
MishiSoza11 visualizações
antihistamine presentation-khall.ppt por MishiSoza
antihistamine presentation-khall.pptantihistamine presentation-khall.ppt
antihistamine presentation-khall.ppt
MishiSoza11 visualizações
Lecture 4(0).pdf por MishiSoza
Lecture 4(0).pdfLecture 4(0).pdf
Lecture 4(0).pdf
MishiSoza2 visualizações

Último

General Anaesthesia por
General Anaesthesia General Anaesthesia
General Anaesthesia P.N.DESHMUKH
7 visualizações8 slides
TQM ASSIGMENT 3.pdf por
TQM ASSIGMENT 3.pdfTQM ASSIGMENT 3.pdf
TQM ASSIGMENT 3.pdfد حاتم البيطار
8 visualizações11 slides
DEBATE IN CA BLADDER TMT VS CYSTECTOMY por
DEBATE IN CA BLADDER TMT VS CYSTECTOMYDEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMYKanhu Charan
36 visualizações42 slides
LMLR 2023 Back and Joint Pain at 50 por
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50Allan Corpuz
324 visualizações77 slides
status epilepticus-management por
status epilepticus-managementstatus epilepticus-management
status epilepticus-managementVamsi Krishna Koneru
9 visualizações91 slides
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... por
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...PeerVoice
8 visualizações1 slide

Último(20)

General Anaesthesia por P.N.DESHMUKH
General Anaesthesia General Anaesthesia
General Anaesthesia
P.N.DESHMUKH 7 visualizações
DEBATE IN CA BLADDER TMT VS CYSTECTOMY por Kanhu Charan
DEBATE IN CA BLADDER TMT VS CYSTECTOMYDEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMY
Kanhu Charan36 visualizações
LMLR 2023 Back and Joint Pain at 50 por Allan Corpuz
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50
Allan Corpuz324 visualizações
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... por PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice8 visualizações
Anaemia,jaundice.pptx por Reena Gollapalli
Anaemia,jaundice.pptxAnaemia,jaundice.pptx
Anaemia,jaundice.pptx
Reena Gollapalli17 visualizações
PATIENTCOUNSELLING in.pptx por skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi116 visualizações
treatment of oropharyngeal cancer.pptx por Woldemariam Beka
treatment of oropharyngeal cancer.pptxtreatment of oropharyngeal cancer.pptx
treatment of oropharyngeal cancer.pptx
Woldemariam Beka9 visualizações
Depression PPT template por EmanMegahed6
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed619 visualizações
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... por PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice7 visualizações
Referral-system_April-2023.pdf por manali9054
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905437 visualizações
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences por Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Saphnix Lifesciences25 visualizações
sales forecasting (Pharma) por sristi51
sales forecasting (Pharma)sales forecasting (Pharma)
sales forecasting (Pharma)
sristi518 visualizações
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences por Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix LifesciencesPharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Saphnix Lifesciences8 visualizações
MEDICAL RESEARCH.pptx por rishi2789
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptx
rishi278948 visualizações
AntiAnxiety Drugs .pptx por Dr Dhanik Mk
AntiAnxiety Drugs .pptxAntiAnxiety Drugs .pptx
AntiAnxiety Drugs .pptx
Dr Dhanik Mk11 visualizações
STR-324.pdf por phbordeau
STR-324.pdfSTR-324.pdf
STR-324.pdf
phbordeau16 visualizações
Case Study_ AI in the Life Sciences Industry.pptx por Emily Kunka, MS, CCRP
Case Study_ AI in the Life Sciences Industry.pptxCase Study_ AI in the Life Sciences Industry.pptx
Case Study_ AI in the Life Sciences Industry.pptx
Emily Kunka, MS, CCRP33 visualizações
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx por Prithivirajan Senthilkumar
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptxINDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx
Prithivirajan Senthilkumar28 visualizações

ENZYMES dcm.pdf

  • 2. Abbrev’ • NAD(H) = nicotinamide adenine dinucleotide; • THF = tetrahydrofolate • CoA = coenzyme A. • TCA = tricarboxylic acid • PP = pentose phosphate
  • 4. Definition • it is derived from the Greek words en (meaning ‘within’) and zume (meaning ‘yeast’). • Enzymes are biological catalysts (also known as biocatalysts) that speed up biochemical reactions in living organisms • -=Enzymes are protein catalysts that increase the velocity of a chemical reaction and are not consumed during the reaction. • can be extracted from cells and then used to catalyse a wide range of commercially important processes
  • 5. NAMING • Most commonly used enzyme names have the suffix “-ase” attached to the substrate of the reaction (for example, glucosidase and urease) or to a description of the action performed (for example, lactate dehydrogenase and adenylyl cyclase). • [Note: Some enzymes retain their original trivial names, which give no hint of the associated enzymic reaction, for example, trypsin and pepsin
  • 6. Enzyme names and classification • Enzymes typically have common names (often called ‘trivial names’) which refer to the reaction that they catalyse, with the suffix -ase (e.g. oxidase, dehydrogenase, carboxylase), although individual proteolytic enzymes generally have the suffix -in (e.g. trypsin, chymotrypsin, papain). • Often the trivial name also indicates the substrate on which the enzyme acts (e.g. glucose oxidase, alcohol dehydrogenase, pyruvate decarboxylase). • However, some trivial names (e.g. invertase, diastase, catalase) provide little information about the substrate, the product or the reaction involved
  • 7. History • History of Enzymes 1878: Name was used when he was describing the ability of yeast to produce alcohol from sugars • 1897: Eduard Buchner began to study the ability of yeast extracts that lacked any living yeast cells to ferment sugar. • He found that the sugar was fermented even when there were no living yeast cells in the mixture. He named the enzyme that brought about the fermentation of sucrose "zymase".
  • 8. History • In 1907 he received the Nobel Prize in Chemistry “for his biochemical research and his discovery of cell-free fermentation". • 1920s that enzymes were crystallized, revealing that catalytic activity is associated with protein molecules. • For the next 60 years or so it was believed that all enzymes were proteins • 1980s it was found that some ribonucleic acid (RNA) molecules(ribozymes) are also able to exert catalytic effects and play an important role in gene expression
  • 9. Significance They have important roles i. The production of sweetening agents –used within the food-processing industry ii. Modification of antibiotics iii. Enzymes that are used as diagnostic reagents and in clinical therapeutics . Glucose-- iv. They are used in washing powders and various cleaning products-proteases for use in washing powders v. They play a key role in analytical devices and -assays Elisa-that have clinical, forensic and environmental applications.-Technical advantages-Microorganisms are also very amenable to genetic modification to produce novel or altered enzymes, using relatively simple methods vi. Enzymes are essential components of animals, plants and microorganisms, due to the fact that they catalyse and co-ordinate the complex reactions of cellular metabolism
  • 11. Enzymes may be intracellular or extracellular • Although many enzymes are retained within the cell, and may be located in specific subcellular compartments, others are released into the surrounding environment. • The majority of enzymes in industrial use are extracellular proteins from either fungal sources (e.g. Aspergillus species) or bacterial sources (e.g. Bacillus species). Examples of these include α-amylase, cellulase, dextranase, proteases and amyloglucosidase. • Many other enzymes for non-industrial use are intracellular and are produced in much smaller amounts by the cell. Examples of these include asparaginase, catalase, cholesterol oxidase, glucose oxidase and glucose-6-phosphate dehydrogenase
  • 12. Catalytic efficiency • Enzyme-catalyzed reactions are highly efficient, proceeding from 103–108 times faster than uncatalyzed reactions. • The number of molecules of substrate converted to product per enzyme molecule per second is called the turnover number, or k cat, and typically is 102–104s-1.
  • 13. Specificity • Enzymes are highly specific, interacting with one or a few substrates and catalyzing only one type of chemical reaction. • The set of enzymes made in a cell determines which reactions occur in that cell.
  • 14. Holoenzymes, apoenzymes, cofactors, and coenzymes • Some enzymes require molecules other than proteins for enzymic activity. • The term holoenzyme refers to the active enzyme with its nonprotein component, • whereas the enzyme without its nonprotein moiety is termed an apoenzyme and is inactive. • If the nonprotein moiety is a metal ion, such as Zn2+ or Fe2+, it is called a cofactor • If it is a small organic molecule, it is termed a coenzyme. • Coenzymes that only transiently associate with the enzyme are called cosubstrates.
  • 15. • If the coenzyme is permanently associated with the enzyme and returned to its original form, it is called a prosthetic group (FAD . Coenzymes commonly are derived from vitamins. • For example, NAD+ contains niacin, and FAD contains riboflavin
  • 16. Regulation • Enzyme activity can be regulated, that is, increased or decreased, so that the rate of product formation responds to cellular need.
  • 17. Location within the cell • Many enzymes are localized in specific organelles within the cell. • Such compartmentalization serves to isolate the reaction substrate or product from other competing reactions. • This provides a favorable environment for the reaction and organizes the thousands of enzymes present in the cell into purposeful pathways.
  • 18. HOW ENZYMES WORK • The mechanism of enzyme action can be viewed from two different perspectives. • The first treats catalysis in terms of energy changes that occur during the reaction. • That is, enzymes provide an alternate, energetically favorable reaction pathway different from the uncatalyzed reaction. • The second perspective describes how the active site chemically • facilitates catalysis.
  • 19. Action of Enzymes • As catalysts, enzymes are only required in very low concentrations, and they speed up reactions without themselves being consumed during the reaction. • We usually describe enzymes as being capable of catalysing the conversion of substrate molecules into product molecules as follows: • Enzyme Substrate ↔ Product
  • 20. Active sites • Enzyme molecules contain a special pocket or cleft called the active site. • The active site, formed by folding of the protein, contains amino acid side chains that participate in substrate binding and catalysis. • The substrate binds the enzyme, forming an enzyme–substrate (ES) complex. Binding is thought to cause a conformational change in the enzyme (induced fit model) that allows catalysis. • ES is converted to an enzyme–product (EP) complex that subsequently dissociates to enzyme and product
  • 22. Effect of an enzyme on reducing the activation energy required to start a reaction where (a) is uncatalysed and (b) is enzyme-catalysed reaction
  • 23. Formation of product in an enzyme-catalysed reaction, plotted against time.
  • 24. Enzymes are affected by pH and temperature • Various environmental factors are able to affect the rate of enzyme- catalysed reactions through reversible or irreversible changes in the protein structure. • The effects of pH and temperature are generally well understood. • Most enzymes have a characteristic optimum pH at which the velocity of the catalysed reaction is maximal, and above and below which the velocity declines
  • 26. • Thermal denaturation is time dependent, and for an enzyme the term ‘optimum temperature’ has little real meaning unless the duration of exposure to that temperature is recorded. • The thermal stability of an enzyme can be determined by first exposing the protein to a range of temperatures for a fixed period of time, and subsequently measuring its activity at one favourable temperature (e.g. 25°C).
  • 28. inhibitors • Enzymes are sensitive to inhibitors • Substances that reduce the activity of an enzyme-catalysed reaction are known as inhibitors. • They act by either directly or indirectly influencing the catalytic properties of the active site. • Inhibitors can be foreign to the cell or natural components of it. • Those in the latter category can represent an important element of the regulation of cell metabolism. • Many toxins and also many pharmacologically active agents (both illegal drugs and prescription and over-the counter medicines) act by inhibiting specific enzyme-catalysed
  • 29. assignment •Students to do • Competitive inhibitors • Non-competitive
  • 30. Allosteric regulators and the control of enzyme activity • Allosteric enzymes are key regulatory enzymes that control the activities of metabolic pathways by responding to inhibitors and activators • allosteric enzymes there is an area where activity is lower than that of an equivalent ‘normal’ enzyme, and also an area where activity is higher than that of an equivalent ‘normal’ enzyme, with a rapid transition between these two phases. • This is rather like a switch that can quickly be changed from ‘off’ (low activity) to ‘on’ (full activity
  • 31. • Most allosteric enzymes are polymeric—that is, they are composed of at least two (and often many more) individual polypeptide chains. • They also have multiple active sites where the substrate can bind. • Allosteric enzymes have an initially low affinity for the substrate, but when a single substrate molecule binds, this may break some bonds within the enzyme and thereby change the shape of the protein such that the remaining active sites are able to bind with a higher affinity. • Therefore allosteric enzymes are often described as moving from a tensed state or T-state (low affinity) in which no substrate is bound, to a relaxed state or R-state (high affinity) as substrate binds Allosteric regulators and the control of enzyme activity
  • 32. FACTORS AFFECTING REACTION VELOCITY A. Substrate concentration • The rate or velocity of a reaction (v) is the number of substrate molecules converted to product per unit time. • Velocity is usually expressed as μmol of product formed per minute. • The rate of an enzyme-catalyzed reaction increases with substrate concentration until a maximal velocity (Vmax) is reached. • The leveling off of the reaction rate at high substrate concentrations reflects the saturation with substrate of all available binding sites on the enzyme molecules • present.
  • 33. • B. Temperature • Increase of velocity with temperature: • The reaction velocity increases with temperature until a peak velocity is reached . • This increase is the result of the increased number of molecules having sufficient energy to pass over the energy barrier and form the products of the reaction. • Decrease of velocity with higher temperature: • Further elevation of the temperature causes a decrease in reaction velocity as a result of temperature induced denaturation of the enzyme • Nb; The optimum temperature for most human enzymes is between 35°C and 40°C. • Human enzymes start to denature at temperatures above 40°C, but thermophilic bacteria found in the hot springs have optimum temperatures of 70°C. FACTORS AFFECTING REACTION VELOCITY
  • 34. • C. pH • The concentration of protons (H+) affects reaction velocity in several ways • catalytic process usually requires that the enzyme and substrate have specific chemical groups in either an ionized or un-ionized state in order to interact .e.g. catalytic activity may require that an amino group of the enzyme be in the protonated form (–NH3+). • Effect of pH on enzyme denaturation: • Extremes of pH can also lead to denaturation of the enzyme, because the structure of the catalytically active protein molecule depends on the ionic character of the amino acid side chains FACTORS AFFECTING REACTION VELOCITY
  • 35. PH cont’d • Variable pH optimum: The pH at which maximal enzyme activity is achieved is different for different enzymes and often reflects the [H+] at which the enzyme functions in the body. • For example, pepsin, a digestive enzyme in the stomach, is maximally active at pH 2, whereas other enzymes, designed to work at neutral pH, are denatured by such an acidic environment
  • 36. Name of the enzyme Optimum pH Trypsin 7.6 Pepsin 2-2.5 Acid phosphatase 5 Alkline phosphatase 9-10 1. Metabolic pathways are controlled by regulating enzyme activity. If enzyme activity is not regulated, it can harm cellular activities and may lead to the development of diseases
  • 37. Activity/substrate profiles of allosteric (⚬) and non-allosteric (•) enzymes with the same affinity and maximal velocity
  • 40. PROPERTIES OF ENZYMES e-mail: charlesnganga069a@gmail.com Catalytic Property, Specificity, Reversibility, and Sensitivity to Heat and pH
  • 55. For detailed description of this topic, please click on: https://www.easybiologyclass.com/properties-of-enzymes- biochemistry-lecture-notes/
  • 56. Nature of Enzymes • Enzymes are specific catalysts • enzymes also possess remarkable specificity in that they generally catalyse the conversion of only one type (or at most a range of similar types) of substrate molecule into product molecules. E.g. glucose oxidase shows almost total specificity for its substrate, β-D-glucose
  • 57. Nature of Enzymes • Two categories dependant on: the presence and absence of a nonprotein component i. Simple enzyme: made up of only protein molecules not bound to any nonproteins, e.g. Pancreatic Ribonuclease. ii. Holo enzyme(apoenzyme) -made up of protein groups and non- protein component. non-protein component here includes- (Fe 2+, Mn 2+, or Zn 2+ ions).
  • 58. COENZYMES a) Coenzymes are derivatives of vitamins without which the enzyme cannot exhibit any reaction. One molecule of coenzyme is able to convert a large number of substrate molecules with the help of enzyme. i. Coenzyme accepts a particular group removed from the substrate or donates a particular group to the substrate ii. Coenzymes are called co substrate because the changes that take place in substrates are complimentary to the changes in coenzymes. iii. The coenzyme may participate in forming an intermediate enzyme- substrate complex Example: NAD, FAD, Coenzyme A
  • 59. Metal ions in enzymes Many enzymes require metal ions like ca2+, K+, Mg2+, Fe2+, Cu2+, Zn2+, Mn2+ and Co2+ for their activity. Metal-activated enzymes-form only loose and easily dissociable complexes with the metal and can easily release the metal without Denaturation. Metalloenzymes hold the metal tightly on the molecule and do not release it even during extensive purification.
  • 60. Metal ions in enzymes Metal ions promote enzyme action by •Maintaining or producing the active structural conformation of the enzyme (e.g. glutamine synthase) •Promoting the formation of the enzyme-substrate complex (Example: Enolase and carboxypeptidase A.) •Acting as electron donors or acceptors (E.g. : Fe-S proteins and cytochromes) •Causing distortions in the substrate or the enzyme E.g. phosphotransferases).
  • 61. The six major classes of enzymes with some example are
  • 62. The six major classes of enzymes with some example are 1. Oxidoreductases • They catalyze oxidation and reduction reactions 2. Tranferases • They catalyze transfer of groups 3. Hydrolases • They catalyze hydrolysis of peptide, ester, glycosyl etc. bonds • 4. Lyases • They catalyze removal of groups from substrates by mechanisms other than hydrolysis forming double bonds
  • 63. The six major classes of enzymes with some example are • 5. Isomerases • They catalyze interconversion of optical, functional and geometrical isomers. • 6. Ligases • They catalyze linking together of two compounds. The linking is coupled to the breaking of phosphate from ATP
  • 64. clinically important enzymes • Some of the clinically important enzymes which are routinely measured in clinical chemistry laboratory are: 1. Alkaline phosphatase • This enzyme catalyzes the hydrolysis of organic esters at alkaline pH 9.0, hence the name alkaline phosphatase. The normal level is 20-90 units/L. The level of the enzyme is elevated in rickets, obstructive jaundice, hyper para thyroidism, metastatic cancer, bone cancer and osteomalacia. In obstructive jaundice 2. Acid phosphatase • This enzyme catalyzes the hydrolysis of organic esters at acidic pH (5.0) hence the name acid phosphatase. The normal level of the enzyme is 2.5-12.0 units/L. It is increased in prostrate cancer. Small increase are seen in bone disease and breast cancer
  • 65. 3. Transminases Aspartate aminoa transferase (AST) and alanine amino transferase (ALT) are two transaminases most frequently measured. Normal levels are 3-20 U/L for AST and 4-20 U/L for ALT (Units-U).
  • 66. clinically important enzymes 4. γ-glutamyl trans peptidase (GGT) • It is involved in the degradation of glutathione. Its level is increased in alcoholic cirrhosis. The normal plasma level of GGT is less than 30 units/L. Since this enzyme is secreted into bile by liver, like alkaline phosphatase γ-glutamyl trans peptidase level increases in cholestatic or obstructive jaundice. It is also elevated in brain lesions. 5. Creatine phosphokinase (CK) • The normal level of this enzyme in plasma is 12-60 U/l. Since skeletal muscle is rich in CK serum CK level raises in disease effecting skeletal muscle. Its level is elevated in muscular dystrophy, polymyositis, severe muscle exercise, muscle injury, hypothyroidism, epileptic seizures and in tetanus. • CK level is also elevated in diseases affecting cardiac muscle because of its high content in it. CK level is elevated in myocardial infarction
  • 67. clinically important enzymes 6. Lactate dehydrogenase (LDH) • The LDH normal level is 70-90 units/L. LDH levels are elevated in myocardial infraction. The serum LDH level raises within 24 hours after infraction, reaches peak level around 2-3 days and returns to normal in a week. Serum LDH level is also elevated in pernicious anemia, megaloblastic anemia, acute hepatitis, blood cancer and in progressive muscular dystrophy. 7. Isocitrate dehydrogenase • The normal level of this enzyme in plasma is 1-5 Units/L. Its level is elevated in inflammatory diseases of liver like infective heptatitis, toxic hepatitis. In obstructive jaundice, its level
  • 68. clinically important enzymes 8. Amylase • The normal range of this enzyme in plasma is 800-1800 Units/L. This enzyme is secreted by pancreas and salivary glands. So, its level is elevated mainly in acute pancreatitis and parotitis. • Its level raised in other conditions like intestinal obstruction and in mumps. 9. Lipase • It is an enzyme produced by pancreas. It is secreted into duodenum through pancreatic duct. The normal level of this enzyme is up to 150 Units/L. It is mainly elevated in acute pancreatitis and pancreas cancer. • It is also elevated in patients with abdominal lesions, perforated peptic ulcer, intestinal obstruction and in acute peritonitis.
  • 69. charles ng'ang'a d/cm march 2020